Device Trial Radar · NCT03859310
Precision of OCT and OCTA-based Ocular Measurements
Last checked: Nov 20, 2026Latest source record: Sep 3, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
144
Actual
Start
Jan 29, 2019
Primary completion
Jul 10, 2019
Study completion Aug 30, 2019
Sponsor
- Lead sponsor
- OptovueNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 1, 2019
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Precision of OCT- and OCTA-based Ocular Measurements
Conditions
- Normal Eyes and Ocular Pathology
Interventions
SD-OCTDevice
Spectral Domain Optical Coherence Tomography for non-invasive, light-based, cross-sectional imaging of ocular structures
Primary outcomes
What the sponsor says the trial is designed to measure.
- Repeatability and Reproducibility Standard Deviation of ocular measurementsTime frame: Day 1
Locations
1 site in 1 country. Site status is shown where the registry gives one.
AMA
Marysville, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.